相关实验视频
Updated: Jan 18, 2026

08:58
Murine Kidney Transplant Technique
Published on: October 20, 2015
17.2K
针对儿科急性肝衰竭患者的连续替代疗法中不同抗凝方法的比较:一项追溯观察性研究
1Pediatric Intensive Care Unit, The Affiliated Children's Hospital of Xiangya School of Medicine, Central South University/Hunan Children's Hospital, Changsha, China.
Frontiers in pediatrics
|September 11, 2025
概括
区域酸盐抗凝药 (RCA) 和纳法莫斯塔特甲基酸盐 (NM) 提供比全身肝素抗凝药 (SHA) 更好的过寿命和安全性,用于持续置换疗法 (CRRT) 的儿科急性肝功能衰竭患者. 由于较少的代谢问题,NM可能会被优先考虑.
科学领域:
- 儿科病学 儿科病学
- 关键护理医学 关键护理医学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 需要持续代疗法 (CRRT) 的儿科急性肝衰竭 (ALF) 患者由于出血风险和高凝血性而存在独特的抗凝血挑战.
- 最佳的抗凝策略对于保持CRRT电路通透性和患者安全在这个脆弱人群中至关重要.
研究的目的:
- 评估和比较不同抗凝策略在接受CRRT的儿科ALF患者的疗效和安全性.
- 具体来说,通过各种抗凝方法来评估波器寿命和新的临床出血事件的发生率.
主要方法:
- 在2017年1月至2023年12月期间接受CRRT的51名儿科ALF患者的回顾性分析.
- 患者根据抗凝剂分为三个组:全身肝素抗凝剂 (SHA),区域酸盐抗凝剂 (RCA) 和纳法莫斯塔特甲基酸盐 (NM).
- 主要结局指标包括过器寿命和新的临床出血事件的发生.
主要成果:
- 与RCA和NM组相比,SHA组的过器寿命显著缩短 (37.0h对43.0h对43.0h,P=0.003).
- 新出血发作的发生率在SHA组 (36.8%) 显著高于RCA (6.7%) 和NM (5.9%) 组 (P=0.036).
- 代谢性和低血症在RCA组中更为普遍. 多变量分析表明,与SHA.相比,RCA和NM都降低了过器凝血风险.
结论:
- 区域酸盐抗凝药 (RCA) 和纳法莫斯塔特甲基酸盐 (NM) 在CRRT的儿科ALF患者中,与全身肝素抗凝药 (SHA) 相比,都提供了优越的过器寿命和出血安全性.
- 与RCA相比,纳法莫斯甲基酸盐 (NM) 可能是首选选择,因为代谢障碍的发生率较低.
- 这些发现支持在接受CRRT的儿科ALF患者中使用RCA或NM而不是SHA用于抗凝药,以优化结果.
相关概念视频
Continuous Renal Replacement Therapy
869
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
869
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
180
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
180
Acute Kidney Injury IV: Diagnostic Studies and Prevention
271
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
271
Acute Kidney Injury V: Interprofessional Care
297
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
297
Renal Drug Clearance: Comparison Between Renal Excretion Methods
564
Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
564
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
233
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
233

